Entasis Therapeutics Holdings Accounts Payable

Entasis Therapeutics Holdings (ETTX) currently reports a accounts payable of $1.8M as of March 2022. That compares with $430K in the prior-year period — up 310.4% year over year. Use the charts on this page to explore Entasis Therapeutics Holdings's accounts payable history and peer comparisons.

Entasis Therapeutics Holdings's accounts payable increased from $430K to $1.8M — a 310.4% year-over-year increase (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Entasis Therapeutics Holdings reported $1.8M in accounts payable as of March 2022. That compares with $430K in the prior-year period — up 310.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Entasis Therapeutics Holdings, and consider following ETTX for alerts when major investors trade the stock.

Entasis Therapeutics Holdings is classified in the Healthcare sector. On accounts payable, it currently shows $1.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ETTX with unrelated industries.